The Australian HCV Point-of-Care Testing Program

Recruiting now

Conditions studied: Hepatitis C

In brief

The National Australian HCV Point-of-Care Testing Program will establish an observational cohort to evaluate whether scale-up of finger-stick point-of-care HCV testing increases diagnosis and treatment for HCV infection. Participants will be recruited from settings providing services to people with a risk factor for the acquisition of HCV infection (including drug treatment clinics, needle and syringe programs, homelessness settings, mental health services, prisons, and mobile outreach). Participants will attend a single visit to have their HCV RNA status tested and complete a self-administered survey. Participants will not receive treatment as a part of this study. Participants who are HCV RNA positive will be linked to standard of care.

Key facts

Study ID

NCT05042544

Run by

Kirby Institute

People needed

60000

Starts

2022-02-23

Expected to finish

2029-06-30

Last updated by the study team

2026-08-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Provided informed consent.
• ≥ 18 years of age.
• Have a risk factor for the acquisition of HCV infection (including current or past injecting drug use, previous incarceration, HIV infection, receiving blood products prior to 1990, having a tattoo or piercing in an unregulated environment, a needle-stick injury, or a mother with HCV).
• OR:
• Are attending a service caring for people with risk factors for the acquisition of HCV infection (e.g. drug treatment clinics, needle and syringe programs, prisons, mobile outreach services, community health services, mental health services, and homelessness services).

You may not qualify if…

• a. Is unable or unwilling to provide informed consent or abide by the requirements of the study.

Where it is running

• Clinic 34 — Alice Springs, Northern Territory, Australia (enrolling)
• Hepatitis QLD — Coorparoo, Queensland, Australia (enrolling)
• ISLHD Drug and Alcohol Service — Wollongong, New South Wales, Australia (enrolling)
• ADSCA - Alice Springs Hospital — Alice Springs, Northern Territory, Australia (enrolling)
• IHWH Micah Projects — Brisbane, Queensland, Australia (enrolling)
• Hepatitis ACT — Canberra, Australian Capital Territory, Australia (enrolling)
• Western NSW LHD — Bathurst, New South Wales, Australia (enrolling)
• Hunter New England LHD — Waratah, New South Wales, Australia (enrolling)
• Nepean Blue Mountains LHD — Penrith, New South Wales, Australia (enrolling)
• North and Mid North Coast LHD — Port Macquarie, New South Wales, Australia (enrolling)
• Central Coast LHD — Gosford, New South Wales, Australia (enrolling)
• Metro North HHS (Biala and Caboolture) — Brisbane, Queensland, Australia (enrolling)
• Kirketon Road Centre — Sydney, New South Wales, Australia (enrolling)
• NSLHD — Sydney, New South Wales, Australia (enrolling)
• WSLHD Drug Health — Sydney, New South Wales, Australia (enrolling)
• South West Sydney LHD — Sydney, New South Wales, Australia (enrolling)
• Hepatitis NSW — Sydney, New South Wales, Australia (enrolling)
• NSW Users and AIDS Association — Sydney, New South Wales, Australia (enrolling)
• Prince of Wales Hospital — Sydney, New South Wales, Australia (enrolling)
• SESLHD Community and Mental Health POCT Allicance (SCAMPA) — Sydney, New South Wales, Australia (enrolling)
• SESLHD Drug Health — Sydney, New South Wales, Australia (enrolling)
• Storr Liver Clinic (Westmead Hospital) — Sydney, New South Wales, Australia (enrolling)
• Sydney Local Health District — Sydney, New South Wales, Australia (enrolling)
• Murrumbidgee & Southern LHD — Wagga Wagga, New South Wales, Australia (enrolling)
• Kombi Clinic — Inala, Queensland, Australia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.